A detailed history of Tredje Ap Fonden transactions in Zoetis Inc. stock. As of the latest transaction made, Tredje Ap Fonden holds 55,572 shares of ZTS stock, worth $9.94 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
55,572
Previous 81,895 32.14%
Holding current value
$9.94 Million
Previous $13.9 Million 30.48%
% of portfolio
0.09%
Previous 0.15%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $3.83 Million - $4.71 Million
-26,323 Reduced 32.14%
55,572 $9.63 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $3.15 Million - $3.8 Million
19,000 Added 30.21%
81,895 $13.9 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $2.89 Million - $3.82 Million
19,080 Added 43.55%
62,895 $12.4 Million
Q3 2023

Nov 09, 2023

SELL
$167.14 - $192.77 $1.1 Million - $1.27 Million
-6,588 Reduced 13.07%
43,815 $7.62 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $1.8 Million - $2.08 Million
11,179 Added 28.5%
50,403 $8.68 Million
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $145,480 - $175,020
1,000 Added 2.62%
39,224 $6.53 Million
Q4 2022

Feb 10, 2023

BUY
$131.14 - $157.47 $1.86 Million - $2.23 Million
14,181 Added 58.98%
38,224 $5.6 Million
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $2.77 Million - $3.42 Million
-18,709 Reduced 43.76%
24,043 $3.57 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $375,371 - $478,744
1,938 Added 4.75%
42,752 $10.4 Million
Q2 2020

Aug 11, 2020

SELL
$111.92 - $142.53 $11.7 Million - $14.8 Million
-104,151 Reduced 71.85%
40,814 $5.59 Million
Q1 2020

May 11, 2020

SELL
$92.66 - $144.94 $1.57 Million - $2.45 Million
-16,904 Reduced 10.44%
144,965 $19.2 Million
Q4 2019

Feb 10, 2020

SELL
$116.25 - $133.25 $957,202 - $1.1 Million
-8,234 Reduced 4.84%
161,869 $21.4 Million
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $855,757 - $976,324
7,602 Added 4.68%
170,103 $21.2 Million
Q2 2019

Aug 09, 2019

SELL
$97.98 - $114.28 $48,108 - $56,111
-491 Reduced 0.3%
162,501 $18.4 Million
Q1 2019

May 10, 2019

SELL
$81.56 - $100.67 $321,183 - $396,438
-3,938 Reduced 2.36%
162,992 $16.4 Million
Q4 2018

Feb 11, 2019

SELL
$79.28 - $95.27 $8.23 Million - $9.89 Million
-103,769 Reduced 38.33%
166,930 $14.3 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $8 Million - $8.94 Million
-95,860 Reduced 26.15%
270,699 $24.8 Million
Q2 2018

Aug 09, 2018

BUY
$79.9 - $89.2 $834,315 - $931,426
10,442 Added 2.93%
366,559 $31.2 Million
Q1 2018

May 09, 2018

SELL
$71.51 - $84.69 $298,911 - $354,004
-4,180 Reduced 1.16%
356,117 $29.7 Million
Q4 2017

Feb 12, 2018

BUY
$63.24 - $72.8 $200,470 - $230,776
3,170 Added 0.89%
360,297 $26 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $21.3 Million - $23.4 Million
357,127
357,127 $22.8 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.